Evidence map›Paper›PMID 38587659›Full record

ReviewRheumatology international2024

Diagnostic delays in systemic vasculitides.

Akerke Auanassova, Marlen Yessirkepov, Olena Zimba, Sakir Ahmed, Prakashini Mruthyunjaya

Abstract readReview
PubMed Publisher
In one paragraph

Review in Rheumatology international, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Late-onset Systemic Lupus Erythematosus.Rheumatology international · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Akerke AuanassovaDepartment of Biology and Biochemistry, South Kazakhstan Medical Academy, Shymkent, Kazakhstan.ORCID 0000-0002-3952-1650
Marlen YessirkepovDepartment of Biology and Biochemistry, South Kazakhstan Medical Academy, Shymkent, Kazakhstan.ORCID 0000-0003-2511-6918
Olena ZimbaDepartment of Clinical Rheumatology and Immunology, University Hospital in Krakow, Krakow, Poland.ORCID 0000-0002-4188-8486
Sakir AhmedDepartment of Clinical Immunology and Rheumatology, Kalinga Institute of Medical Sciences, KIIT University, Bhubaneswar, 751024, India.ORCID 0000-0003-4631-311X
Prakashini MruthyunjayaDepartment of Clinical Immunology and Rheumatology, Kalinga Institute of Medical Sciences, KIIT University, Bhubaneswar, 751024, India. m.v.prakashini@gmail.com.ORCID 0000-0002-1278-6042

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Systemic vasculitides are among the less common disorders encountered in routine rheumatology practice. The low incidence and heterogeneous presentation at onset can potentially lead to delayed diagnosis. Not recognizing these in the early phase may prove detrimental, as some vasculitis may progress to a catastrophic course with major morbidity or mortality. The causes of diagnostic delay may vary among different types of vasculitis and may also be disease-, patient-, or physician-related. Disease-related factors include the myriad presentations with diverse and non-specific symptoms, mimicking other conditions like infections. In addition, some forms have prolonged prodromal phases before evident organ damage. Limited awareness among healthcare professionals, particularly outside rheumatology, and a lack of readily available diagnostic tools contribute to missed diagnoses. Delays in seeking care due to non-specific symptoms or lack of access to specialist care can worsen outcomes. The economic burden also increases with delayed diagnosis and damage accrual when the disease remains unrecognized or untreated for prolonged periods. Although the causes of vasculitis are numerous, including secondary causes, in this review, we focus on diagnostic delays in primary vasculitides and suggest potential steps to identify and treat these diseases early. These include educating both healthcare professionals and the public about the signs and symptoms of vasculitis; expanding the rheumatology workforce and facilitating timely referrals; implementing readily available and reliable tests for early detection; and streamlining care and diagnostic pathways. Such measures have the potential to improve the overall outcomes of the disease, with prolonged remission, minimal damage accrual, and improved quality of life.

Indexed as

Delayed DiagnosisSystemic VasculitisHumansPredictive Value of TestsPrognosisRheumatologyTime FactorsAnti-neutrophil cytoplasmic antibody-associated vasculitisDelayed diagnosesGiant cell arteritisTakayasu arteritisVasculitis

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.